💨 Abstract

President Donald Trump issued an executive order aimed at lowering prescription drug prices by setting a 30-day deadline for drugmakers to reduce prices. If they don’t comply, the U.S. will tie drug prices to the lowest prices paid by other developed countries. However, experts clarify that high U.S. drug prices are due to fragmented negotiation systems with insurers, rather than foreign influence. The order’s impact on private insurance holders is uncertain.

Courtesy: wtop.com